265 patents currently held
32 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Jun 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
26
Ending by 2030
Jun 2027
Next term end
108
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Aug 2034 · High confidence
Also notable
Ends Dec 2028 · High confidence
Also notable
Ends Jun 2033 · High confidence
Also notable
Ends Oct 2033 · High confidence
Also notable
Ends Apr 2033 · High confidence
Also notable
Ends Apr 2032 · High confidence
Also notable
Ends no later than Aug 2033 · Medium confidence
Also notable
Ends Jan 2035 · High confidence
Filamentary Devices for Treatment of Vascular Defects
US 11,723,667
Cited by 25 later US patents, top 5% of utility patents granted in 2023 in our data. Protection runs to 2034. A terminal disclaimer caps this term to an earlier patent's.
Methods and Devices for Treatment of Vascular Defects
US 11,179,159
Cited by 55 later US patents, top 5% of utility patents granted in 2021 in our data. Protection runs to 2028.
Polymeric Treatment Compositions
US 9,937,201
Cited by 90 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Polymeric Treatment Compositions
US 10,258,716
Cited by 309 later US patents, top 1% of utility patents granted in 2019 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2033. A terminal disclaimer caps this term to an earlier patent's.
Obstruction Removal System
US 9,211,132
Cited by 359 later US patents, top 1% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2033.
Implant Delivery Device
US 10,517,604
Cited by 360 later US patents, top 1% of utility patents granted in 2019 in our data. Protection runs to 2032.
Filamentary Devices for Treatment of Vascular Defects
US 9,597,087
Cited by 319 later US patents, top 1% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2033. A terminal disclaimer is on file and its reference is not resolved, so no cap is applied and the date may move earlier, never later.
Polymer Particles
US 9,688,788
Cited by 101 later US patents, top 5% of utility patents granted in 2017 in our data, and renewed at every maintenance window due so far. Protection runs to 2035.
Formerly held, still cited
Notable
Ends Sep 2037 · High confidence
Cited by 296 later US patents, top 1% of utility patents granted in 2019 in our data. Protection runs to 2037.
now held by Terumo Corporation
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 11 fees due Jan 4 to 28, 2027 · next Jan 4
- 9 fees due Feb 1 to 28, 2027 · next Feb 1
- 4 fees due Mar 5 to 19, 2027 · next Mar 5
- 1 fee due Apr 30, 2027The maintenance fee for Polymeric Treatment Compositions (US 11,801,326) comes due Apr 30, 2027. Unpaid by Nov 1, 2027, it lapses early.
- 2 fees due May 7 to 28, 2027 · next May 7
- 4 fees due Jun 1 to 30, 2027 · next Jun 1
- 9 fees due Jul 2 to 30, 2027 · next Jul 2
- 6 fees due Aug 6 to 27, 2027 · next Aug 6
- 7 fees due Sep 3 to 29, 2027 · next Sep 3
- 4 fees due Oct 2 to 14, 2027 · next Oct 2
- 3 fees due Nov 5 to 7, 2027 · next Nov 5
Recent changes
- 5 of the patents on this record were granted since Aug 23, 2026
- 7 terms have ended since Aug 23, 2026
- Nov 15 US 10,857,589 Three-Dimensional Complex Coil · term ended
- Oct 9 US 8,252,040 Aneurysm Treatment Device and Method of Use · term ended
- Oct 9 US 10,092,663 Polymers · lapsed on the fee record
- Oct 7 US 8,182,506 Thermal Detachment System for Implantable Devices · term ended
- Oct 4 US 10,413,302 Thermal Detachment System For Implantable Devices · term ended
- Sep 25 US 10,081,048 Three-Dimensional Complex Coil · lapsed on the fee record
- Aug 30 US 11,426,175 Expansile Member · lapsed on the fee record
What they patent
The largest of its 108 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Braiding Mechanism and Methods of Use | 13 in force | to May 2032 |
| Filamentary Devices for Treatment of Vascular Defects | 11 in force | to Feb 2035 |
| Delivery and Detachment Systems and Methods for Vascular Implants | 10 in force | to May 2039 |
| Embolization Device Constructed from Expansile Polymer | 9 in force | to Jun 2029 |
| Particles | 8 in force | to Mar 2036 |
| Polymeric Treatment Compositions (2013) | 6 in force | to Jun 2033 |
| Embolic Containment | 5 in force | to Jan 2039 |
| Device Delivery System | 5 in force | to Aug 2035 |
| Implant Delivery Device | 5 in force | to Jun 2035 |
| Packing Coil | 5 in force | to Dec 2034 |
| Polymeric Treatment Compositions (2013) | 5 in force | to Oct 2033 |
| Obstruction Removal System | 4 in force | to Oct 2038 |
| Embolic Compositions | 4 in force | to May 2038 |
| Stent | 4 in force | to Jan 2037 |
Patents held now
Soonest term end first.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,451,963 | Embolization Device Constructed From Expansile Polymer In force · High confidence | In force | High confidence | |
| US 9,724,103 | Embolization Device Constructed from Expansile Polymer In force · High confidence | In force | High confidence | |
| US 9,877,731 | Embolization Device Constructed From Expansile Polymer In force · High confidence | In force | High confidence | |
| US 10,226,258 | Embolization Device Constructed from Expansile Polymer In force · High confidence | In force | High confidence | |
| US 10,499,925 | Embolization Device Constructed From Expansile Polymer In force · High confidence | In force | High confidence | |
| US 11,160,557 | Embolization Device Constructed from Expansile Polymer In force · High confidence | In force | High confidence | |
| US 11,185,336 | Embolization Device Constructed From Expansile Polymer In force · High confidence | In force | High confidence | |
| US 11,707,281 | Thermal Detachment System For Implantable Devices In force · Low confidence | In force | Low confidence | |
| US 9,259,228 | Embolization Device Constructed from Expansile Polymer In force · High confidence | In force | High confidence | |
| US 9,259,337 | Methods and Devices for Treatment of Vascular Defects In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 265: 32 patents in force now held by others · 28 patents ended · 114 applications pending · 52 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.